Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders. The company is developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer improved disease ... Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders. The company is developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia (CAH). 詳細を表示
Topline Data from CAHmelia-204 Study of Tildacerfont in Adult Congenital Adrenal Hyperplasia (CAH) Anticipated in December 2024 Topline Data from CAHptain-205 Study of Tildacerfont in Adult and...
Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for endocrine and neurological disorders with significant...
Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for endocrine and neurological disorders with significant...
Announced Strategic Collaboration with HMNC Brain Health GmbH (HMNC) to Develop Tildacerfont for the Treatment of Major Depressive Disorder (MDD) Topline Data from CAHmelia-204 Study of...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0347 | 6.80792623112 | 0.5097 | 0.57 | 0.4758 | 236777 | 0.5033472 | CS |
4 | -0.0454 | -7.6975245846 | 0.5898 | 0.5898 | 0.4726 | 272655 | 0.52166701 | CS |
12 | 0.0921 | 20.3625912005 | 0.4523 | 0.608 | 0.42 | 397985 | 0.49357596 | CS |
26 | -0.1485 | -21.4316640208 | 0.6929 | 0.7466 | 0.41115 | 428566 | 0.52630413 | CS |
52 | -0.8556 | -61.1142857143 | 1.4 | 5.95 | 0.41115 | 618758 | 1.21501056 | CS |
156 | -2.2556 | -80.5571428571 | 2.8 | 5.95 | 0.41115 | 715669 | 2.94624231 | CS |
260 | -16.4556 | -96.7976470588 | 17 | 35.6 | 0.41115 | 540458 | 3.38189497 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約